Cargando…

LRP1B mutation is associated with tumor HPV status and promotes poor disease outcomes with a higher mutation count in HPV-related cervical carcinoma and head & neck squamous cell carcinoma

Human papillomavirus (HPV) infection and gene mutations were reputed as key factors in cervical carcinoma (CC) and head and neck squamous cell carcinoma (HNSCC). However, the associations of HPV status and gene mutations remain to be determined. This study aims to identify molecular patterns of LRP1...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Can-hui, Liu, Rang, Lin, Xin-ran, Luo, Jia-qi, Cao, Li-juan, Zhang, Qiu-ju, Lin, Shou-ren, Geng, Lan, Sun, Zhong-yi, Ye, Si-kang, Yu, Zhi-ying, Shi, Yu, Xia, Xi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120457/
https://www.ncbi.nlm.nih.gov/pubmed/33994859
http://dx.doi.org/10.7150/ijbs.56970
_version_ 1783692101681152000
author Cao, Can-hui
Liu, Rang
Lin, Xin-ran
Luo, Jia-qi
Cao, Li-juan
Zhang, Qiu-ju
Lin, Shou-ren
Geng, Lan
Sun, Zhong-yi
Ye, Si-kang
Yu, Zhi-ying
Shi, Yu
Xia, Xi
author_facet Cao, Can-hui
Liu, Rang
Lin, Xin-ran
Luo, Jia-qi
Cao, Li-juan
Zhang, Qiu-ju
Lin, Shou-ren
Geng, Lan
Sun, Zhong-yi
Ye, Si-kang
Yu, Zhi-ying
Shi, Yu
Xia, Xi
author_sort Cao, Can-hui
collection PubMed
description Human papillomavirus (HPV) infection and gene mutations were reputed as key factors in cervical carcinoma (CC) and head and neck squamous cell carcinoma (HNSCC). However, the associations of HPV status and gene mutations remain to be determined. This study aims to identify molecular patterns of LRP1B mutation and HPV status via rewiring tumor samples of HNSCC (n=1478) and CC (n=178) from the TCGA dataset. Here, we found that LRP1B mutation was associated with HPV status in CC (P=0.040) and HNSCC (P=0.044), especially in HPV 16 integrated CC (P=0.036). Cancer survival analysis demonstrated that samples with LRP1B mutation showed poor disease outcomes in CC (P=0.013) and HNSCC (P=0.0124). In addition, the expression status of LPR1B was more favorable for prediction than TP53 or RB1 in CC and HNSCC. Mutation clustering analysis showed that samples with LRP1B mutation showed higher mutation count in CC (P=1.76e-67) and HNSCC (P<10e-10). Further analysis identified 289 co-occurrence genes in these two cancer types, which were enriched in PI3K signaling, cell division process, and chromosome segregation process, et al. The 289-co-occurrence gene signature identified a cluster of patients with a higher portion of copy number variation (CNV) lost in the genome, different tumor HPV status (P<10e-10), higher mutation count (P<10e-10), higher fraction genome altered value (P=2.078e-4), higher aneuploidy score (P=3.362e-4), and earlier started the smoking year (P=2.572e-4), which were associated with shorter overall survival (P=0.0103) in CC and HNSCC samples. Overall, LRP1B mutation was associated with tumor HPV status and was an unfavorable prognostic biomarker for CC and HNSCC.
format Online
Article
Text
id pubmed-8120457
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-81204572021-05-14 LRP1B mutation is associated with tumor HPV status and promotes poor disease outcomes with a higher mutation count in HPV-related cervical carcinoma and head & neck squamous cell carcinoma Cao, Can-hui Liu, Rang Lin, Xin-ran Luo, Jia-qi Cao, Li-juan Zhang, Qiu-ju Lin, Shou-ren Geng, Lan Sun, Zhong-yi Ye, Si-kang Yu, Zhi-ying Shi, Yu Xia, Xi Int J Biol Sci Research Paper Human papillomavirus (HPV) infection and gene mutations were reputed as key factors in cervical carcinoma (CC) and head and neck squamous cell carcinoma (HNSCC). However, the associations of HPV status and gene mutations remain to be determined. This study aims to identify molecular patterns of LRP1B mutation and HPV status via rewiring tumor samples of HNSCC (n=1478) and CC (n=178) from the TCGA dataset. Here, we found that LRP1B mutation was associated with HPV status in CC (P=0.040) and HNSCC (P=0.044), especially in HPV 16 integrated CC (P=0.036). Cancer survival analysis demonstrated that samples with LRP1B mutation showed poor disease outcomes in CC (P=0.013) and HNSCC (P=0.0124). In addition, the expression status of LPR1B was more favorable for prediction than TP53 or RB1 in CC and HNSCC. Mutation clustering analysis showed that samples with LRP1B mutation showed higher mutation count in CC (P=1.76e-67) and HNSCC (P<10e-10). Further analysis identified 289 co-occurrence genes in these two cancer types, which were enriched in PI3K signaling, cell division process, and chromosome segregation process, et al. The 289-co-occurrence gene signature identified a cluster of patients with a higher portion of copy number variation (CNV) lost in the genome, different tumor HPV status (P<10e-10), higher mutation count (P<10e-10), higher fraction genome altered value (P=2.078e-4), higher aneuploidy score (P=3.362e-4), and earlier started the smoking year (P=2.572e-4), which were associated with shorter overall survival (P=0.0103) in CC and HNSCC samples. Overall, LRP1B mutation was associated with tumor HPV status and was an unfavorable prognostic biomarker for CC and HNSCC. Ivyspring International Publisher 2021-04-22 /pmc/articles/PMC8120457/ /pubmed/33994859 http://dx.doi.org/10.7150/ijbs.56970 Text en © The author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Cao, Can-hui
Liu, Rang
Lin, Xin-ran
Luo, Jia-qi
Cao, Li-juan
Zhang, Qiu-ju
Lin, Shou-ren
Geng, Lan
Sun, Zhong-yi
Ye, Si-kang
Yu, Zhi-ying
Shi, Yu
Xia, Xi
LRP1B mutation is associated with tumor HPV status and promotes poor disease outcomes with a higher mutation count in HPV-related cervical carcinoma and head & neck squamous cell carcinoma
title LRP1B mutation is associated with tumor HPV status and promotes poor disease outcomes with a higher mutation count in HPV-related cervical carcinoma and head & neck squamous cell carcinoma
title_full LRP1B mutation is associated with tumor HPV status and promotes poor disease outcomes with a higher mutation count in HPV-related cervical carcinoma and head & neck squamous cell carcinoma
title_fullStr LRP1B mutation is associated with tumor HPV status and promotes poor disease outcomes with a higher mutation count in HPV-related cervical carcinoma and head & neck squamous cell carcinoma
title_full_unstemmed LRP1B mutation is associated with tumor HPV status and promotes poor disease outcomes with a higher mutation count in HPV-related cervical carcinoma and head & neck squamous cell carcinoma
title_short LRP1B mutation is associated with tumor HPV status and promotes poor disease outcomes with a higher mutation count in HPV-related cervical carcinoma and head & neck squamous cell carcinoma
title_sort lrp1b mutation is associated with tumor hpv status and promotes poor disease outcomes with a higher mutation count in hpv-related cervical carcinoma and head & neck squamous cell carcinoma
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120457/
https://www.ncbi.nlm.nih.gov/pubmed/33994859
http://dx.doi.org/10.7150/ijbs.56970
work_keys_str_mv AT caocanhui lrp1bmutationisassociatedwithtumorhpvstatusandpromotespoordiseaseoutcomeswithahighermutationcountinhpvrelatedcervicalcarcinomaandheadnecksquamouscellcarcinoma
AT liurang lrp1bmutationisassociatedwithtumorhpvstatusandpromotespoordiseaseoutcomeswithahighermutationcountinhpvrelatedcervicalcarcinomaandheadnecksquamouscellcarcinoma
AT linxinran lrp1bmutationisassociatedwithtumorhpvstatusandpromotespoordiseaseoutcomeswithahighermutationcountinhpvrelatedcervicalcarcinomaandheadnecksquamouscellcarcinoma
AT luojiaqi lrp1bmutationisassociatedwithtumorhpvstatusandpromotespoordiseaseoutcomeswithahighermutationcountinhpvrelatedcervicalcarcinomaandheadnecksquamouscellcarcinoma
AT caolijuan lrp1bmutationisassociatedwithtumorhpvstatusandpromotespoordiseaseoutcomeswithahighermutationcountinhpvrelatedcervicalcarcinomaandheadnecksquamouscellcarcinoma
AT zhangqiuju lrp1bmutationisassociatedwithtumorhpvstatusandpromotespoordiseaseoutcomeswithahighermutationcountinhpvrelatedcervicalcarcinomaandheadnecksquamouscellcarcinoma
AT linshouren lrp1bmutationisassociatedwithtumorhpvstatusandpromotespoordiseaseoutcomeswithahighermutationcountinhpvrelatedcervicalcarcinomaandheadnecksquamouscellcarcinoma
AT genglan lrp1bmutationisassociatedwithtumorhpvstatusandpromotespoordiseaseoutcomeswithahighermutationcountinhpvrelatedcervicalcarcinomaandheadnecksquamouscellcarcinoma
AT sunzhongyi lrp1bmutationisassociatedwithtumorhpvstatusandpromotespoordiseaseoutcomeswithahighermutationcountinhpvrelatedcervicalcarcinomaandheadnecksquamouscellcarcinoma
AT yesikang lrp1bmutationisassociatedwithtumorhpvstatusandpromotespoordiseaseoutcomeswithahighermutationcountinhpvrelatedcervicalcarcinomaandheadnecksquamouscellcarcinoma
AT yuzhiying lrp1bmutationisassociatedwithtumorhpvstatusandpromotespoordiseaseoutcomeswithahighermutationcountinhpvrelatedcervicalcarcinomaandheadnecksquamouscellcarcinoma
AT shiyu lrp1bmutationisassociatedwithtumorhpvstatusandpromotespoordiseaseoutcomeswithahighermutationcountinhpvrelatedcervicalcarcinomaandheadnecksquamouscellcarcinoma
AT xiaxi lrp1bmutationisassociatedwithtumorhpvstatusandpromotespoordiseaseoutcomeswithahighermutationcountinhpvrelatedcervicalcarcinomaandheadnecksquamouscellcarcinoma